Hangzhou AGS MedTech Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 18.80%

Hangzhou AGS MedTech Co. Ltd. A (688581) has an Asset Resilience Ratio of 18.80% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥507.20 Million

≈ $74.22 Million USD Cash + Short-term Investments

Total Assets

CN¥2.70 Billion

≈ $394.83 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how Hangzhou AGS MedTech Co. Ltd. A's Asset Resilience Ratio has changed over time. See Hangzhou AGS MedTech Co. Ltd. A (688581) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Hangzhou AGS MedTech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688581 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥507.20 Million	18.8%
Total Liquid Assets	CN¥507.20 Million	18.80%

Asset Resilience Insights

Good Liquidity Position: Hangzhou AGS MedTech Co. Ltd. A maintains a healthy 18.80% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Hangzhou AGS MedTech Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Hangzhou AGS MedTech Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
APT Medical Inc SHG:688617	Medical Devices	8.63%
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Shanghai MicroPort EV MedTech Co. Ltd. A SHG:688351	Medical Devices	49.23%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Shanghai General Healthy Information and Technology Co. Ltd. SHG:605186	Medical Devices	0.84%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A SHE:002932	Medical Devices	34.47%

Annual Asset Resilience Ratio for Hangzhou AGS MedTech Co. Ltd. A (2021–2025)

The table below shows the annual Asset Resilience Ratio data for Hangzhou AGS MedTech Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	22.13%	CN¥592.42 Million ≈ $86.69 Million	CN¥2.68 Billion ≈ $391.68 Million	-4.19pp
2024-12-31	26.32%	CN¥671.22 Million ≈ $98.22 Million	CN¥2.55 Billion ≈ $373.11 Million	+22.79pp
2023-12-31	3.54%	CN¥82.42 Million ≈ $12.06 Million	CN¥2.33 Billion ≈ $341.11 Million	-8.09pp
2022-12-31	11.63%	CN¥55.01 Million ≈ $8.05 Million	CN¥473.13 Million ≈ $69.23 Million	+11.31pp
2021-12-31	0.32%	CN¥1.09 Million ≈ $159.70K	CN¥341.99 Million ≈ $50.04 Million	--

pp = percentage points

About Hangzhou AGS MedTech Co. Ltd. A

SHG:688581 China Medical Devices

Market Cap

$607.54 Million

CN¥4.15 Billion CNY

Market Cap Rank

#11018 Global

#2931 in China

Share Price

CN¥51.18

Change (1 day)

-1.29%

52-Week Range

CN¥49.78 - CN¥87.93

All Time High

CN¥92.52